recombinant interleukin-21 (rIL-21)

interleukin-21 · Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for recombinant interleukin-21 (rIL-21), covering 2017-03-01 to 2017-03-01. Get the full timeline:

Most recent: Clinical Trial Update: Effect of rIL-21 on Metastases in Lymph Nodes in Melanoma Skin Cancer [Phase 2]